Biora Therapeutics
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2010-01-01
- Employees
- 58
- Market Cap
- $25M
- Introduction
Biora Therapeutics, Inc. engages in the provision of molecular and specialized diagnostic tests to clinicians. Its products include the Preparent Carrier Test, Innatal Prenatal Screen, Riscover Hereditary Cancer Test, and Resura Prenatal Test. The company was founded by Paul W. Hawran and Harry Stylli in 2010 and is headquartered in San Diego, CA.
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)BT-600 Single and Multiple Ascending Oral Doses in Healthy Adult Subjects
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2024-02-23
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Biora Therapeutics, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT06275464
- Locations
- 🇺🇸
Celerion, Lincoln, Nebraska, United States
News
No news found